Jeanne Marrazzo to be Anthony Fauci’s alternative as NIAID director
A well being skilled on the College of Alabama has been named the subsequent director of the Nationwide Institute of Allergy and Infectious Ailments (NIAID), the Nationwide Institutes of Well being introduced this week.
Dr. Jeanne Marrazzo is predicted to start out the job this fall, the NIH mentioned in an announcement launched Wednesday. Dr. Anthony Fauci retired from the submit in December.
The federal company is likely one of the 27 institutes and facilities that make up the Nationwide Institutes of Well being, an company of america Division of Well being and Human Providers. Dr. Hugh Auchincloss Jr. has served as appearing director since Fauci stepped down.
Marrazzo is at the moment the director of the Division of Infectious Ailments on the college’s medical college in Birmingham.
In a joint assertion from the college’s President Ray Watts and Dr. Anupam Agarwal, senior vice chairman of drugs on the college, the pair referred to as Marrazzo’s appointment “an awesome alternative for her to make an enormous distinction to the nation, and it’s indicative of the excessive regard that exists for each her and UAB.”
“Whereas we’re unhappy to see her go, we’re delighted that Jeanne has been referred to as to this nationwide service and we’re proud to rely her as one in every of us at (the college),” the assertion continued.
“Dr. Marrazzo brings a wealth of management expertise from main worldwide scientific trials and translational analysis, managing a posh organizational price range that features analysis funding and mentoring trainees in all phases {of professional} improvement,” Auchincloss mentioned. “I look ahead to welcoming Dr. Marrazzo to the NIH management staff. I additionally wish to prolong my gratitude to Hugh Auchincloss, Jr., M.D., for serving as appearing director.”
Extra information:Supreme Court docket blocks use of affirmative motion at Harvard, UNC in blow to range efforts
Marrazzo to supervise $6.3 billion price range
In her new function, Marrazzo will oversee NIAID’s $6.3 billion price range which helps analysis in an effort to grasp, diagnose and deal with infectious, immunologic and allergic illnesses.
In line with NIH, NIAID helps analysis at universities and organizations throughout the nation United States and at its 21 laboratories, together with the Vaccine Analysis Middle on NIH’s foremost campus in Bethesda, Maryland, and the Rocky Mountains Laboratories in Hamilton, Montana.
NIAID is remitted to answer rising and re-emerging public well being threats at residence and abroad.
The company’s analysis response to outbreaks of infectious illnesses together with HIV, Ebola and COVID-19, has led to help together with new vaccines, diagnostic checks and different remedies.
Fauci was face of America’s COVID-19 response
Marrazzo’s predecessor Fauci, the general public face of the nation’s COVID-19 response, retired in late 2022.
Fauci’s departure concluded 54 years on the institute and 38 years as director.
“I gave all of it I acquired for a lot of a long time,” Fauci mentioned after saying his retirement. The physician was each lauded by the well being group and criticized by Republicans for restrictions he pushed to halt the unfold of the coronavirus throughout his time within the function on the top of the pandemic.
Fauci couldn’t instantly be reached by USA TODAY Thursday.
Interview:Can we eradicate COVID? That’s a tough no, in keeping with Dr. Anthony Fauci
Who’s Dr. Jeanne Marrazzo?
A Fellow of the American School of Physicians and of the Infectious Ailments Society of America, Marrazzo is board licensed in infectious illness.
In line with NIH, her analysis in discovery and implementation science has targeted on the human microbiome, “particularly because it pertains to feminine reproductive tract infections and hormonal contraception; prevention of HIV an infection utilizing biomedical interventions, together with PrEP and microbicides; and the pathogenesis and administration of bacterial vaginosis, sexually transmitted illnesses in HIV-infected individuals and administration of antibiotic resistance in gonorrhea.”
She can be a recipient of the American Sexually Transmitted Ailments Affiliation’s Distinguished Profession Award, the best recognition of contributions to analysis and mentoring within the discipline.
Marrazzo earned her bachelor’s in biology from Harvard College; her M.D. from Thomas Jefferson College in, Philadelphia; and a Grasp of Public Well being in Epidemiology from the College of Washington in Seattle. She has chaired the American Board of Inside Drugs Council and its Infectious Illness Specialty Board.
Natalie Neysa Alund covers breaking and trending information for USA TODAY. Attain her at nalund@usatoday.com and observe her on Twitter @nataliealund.
